Early-life wheezing and respiratory syncytial virus prevention

N Engl J Med. 2013 May 9;368(19):1839-41. doi: 10.1056/NEJMe1302063.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Female
  • Humans
  • Infant, Premature, Diseases / prevention & control*
  • Male
  • Palivizumab
  • Respiratory Sounds / drug effects*
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Respiratory Syncytial Viruses*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab